Literature DB >> 9280189

Nutritional status and cardiac mass and function in children infected with the human immunodeficiency virus.

T L Miller1, E J Orav, S D Colan, S E Lipshultz.   

Abstract

Malnutrition, skeletal muscle wasting, and changes in cardiac muscle mass and function have been described in children infected with the human immunodeficiency virus (HIV). This report analyzes the relation of nutritional status to cardiac muscle mass and function in HIV-infected children. Thirty-six children with symptomatic HIV infection underwent simultaneous anthropometric and echocardiographic evaluations before antiretroviral therapy or supplemental feedings. Nutritional measurements included weight, height, triceps skinfold thickness, and arm muscle circumference. Cardiac measurements included left ventricular mass, contractility, end-diastolic dimension, fractional shortening, blood pressure, and heart rate. In a cross-sectional analysis, children infected with HIV were significantly below age-adjusted standards for height (P = 0.0001), weight (P = 0.0001), triceps skinfold thickness (P = 0.001), and arm muscle circumference (P = 0.04). Left ventricular mass normalized to body surface area was below standard, but contractility was normal. Correlation analyses found an inverse relation between left ventricular mass and weight z score (r = -0.45, P = 0.01), height z score (r = -0.47, P = 0.006), and arm muscle circumference percentile (r = -0.51, P = 0.003). An inverse relation was also found between heart rate and weight z score (r = -0.47, P = 0.007) and arm muscle circumference percentile (r = -0.46, P = 0.007). In malnourished children with HIV infection, a paradoxical relation exists between nutritional status and cardiac muscle mass. The inverse relation between heart rate and nutritional status may suggest altered metabolic rates with possible increased sympathetic tone.

Entities:  

Mesh:

Year:  1997        PMID: 9280189     DOI: 10.1093/ajcn/66.3.660

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; K McIntosh; M D Schluchter; S D Colan
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

2.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11

3.  Cardiac anomalies in a group of HIV-infected children in a pediatric hospital: an echocardiographic study in Yaounde, Cameroon.

Authors:  David Chelo; Edvine Wawo; Valentin Siaha; Aurelien Anakeu; Francis Ateba Ndongo; Paul Olivier Koki Ndombo; Samuel Kingue
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

Review 4.  Myocardial disease in human immunodeficiency virus (HIV) infection: a review.

Authors:  Mahmoud Umar Sani
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection.

Authors:  Robert F Miller; Juan P Kaski; James Hakim; Jonathan Matenga; Kusum Nathoo; Shungu Munyati; Sujal R Desai; Elizabeth L Corbett; Rashida A Ferrand
Journal:  Clin Infect Dis       Date:  2012-10-24       Impact factor: 9.079

6.  Clinical diagnosis of cardiac involvement in HIV infection.

Authors:  L Moldovan; O Branzan; O Nechita; C Ardeleanu; M Teodorescu; A Geamai
Journal:  J Med Life       Date:  2012-09-25

7.  Left ventricular systolic function in Nigerian children infected with HIV/AIDS: a cross-sectional study.

Authors:  Ijeoma Arodiwe; Anthony Ikefuna; Egbuna Obidike; Ejikeme Arodiwe; Bennedict Anisuba; Ngozi Ibeziako; Sunday Omokoidion; Christy Okoroma
Journal:  Cardiovasc J Afr       Date:  2016 Jan-Feb       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.